Skip to main content
. 2015 Apr 8;5(3):277–284. doi: 10.1016/j.apsb.2015.02.001

Figure 2.

Figure 2

Protective effect of GR on cerebral ischemic injury. (A) Infarct images observed using 2,3,5-triphenyltetrazolium chloride staining on day 3 after MCAO (n=10). (B) Significant reduction in infarct volume in the GR 30 mg/kg treatment group and 60 mg/kg treatment group compared with the model group consistent with the results predicted by the enter regression and stepwise models. (C) Neurological scores at 24 h after MCAO, the scores of control group was zero, data not shown. ⁎P<0.05; ⁎⁎P<0.01.